A Safety and Tolerability Study of ABT-126 in Elderly

Safety and Efficacy Study of ABT-089 in Adults With Mild to Moderate Alzheimer's Disease

NCT00555204 ·Status: TERMINATED ·Phase: PHASE2

Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease

NCT01527916 ·Status: COMPLETED ·Phase: PHASE2

Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors

NCT01549834 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABT-957 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors

NCT02220738 ·Status: TERMINATED ·Phase: PHASE1

Efficacy and Safety Study for Subjects With Mild-to-Moderate Alzheimer's Disease

NCT00948909 ·Status: COMPLETED ·Phase: PHASE2

Safety, Tolerability, and Pharmacokinetics of ABT-354 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors

NCT01908010 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety Study of ABT-384 in Subjects With Mild-to-Moderate Alzheimer's Disease

NCT01137526 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety Study of ABT-288 in Subjects With Mild-to-Moderate Alzheimer's Disease

NCT01018875 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of MABT5102A in Patients With Mild to Moderate Alzheimer's Disease (ABBY)

NCT01343966 ·Status: COMPLETED ·Phase: PHASE2

A Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Anti-Abeta (MABT5102A) in Patients With Alzheimer's Disease

NCT00736775 ·Status: COMPLETED ·Phase: PHASE1

Safety and Tolerability of AFFITOPE AD03

NCT01309763 ·Status: COMPLETED ·Phase: PHASE1

A Study of LY3372689 to Assess the Safety, Tolerability, and Efficacy in Participants With Alzheimer's Disease

NCT05063539 ·Status: COMPLETED ·Phase: PHASE2

Safety, Tolerability and the Effects on Cerebrospinal Fluid Spectrin Breakdown Product-145 Levels of ABT-957 in Subjects With Mild Alzheimer's Disease and Mild Cognitive Impairment

NCT02573740 ·Status: TERMINATED ·Phase: PHASE1

A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-355

NCT03802162 ·Status: COMPLETED ·Phase: PHASE1

Single Ascending Dose Study of BIIB037 in Participants With Alzheimer's Disease

NCT01397539 ·Status: COMPLETED ·Phase: PHASE1

Long-term Safety and Tolerability of AFFITOPE AD01

NCT00711139 ·Status: COMPLETED

A Two-part Multiple Dose Study to Assess the Safety and Effects of AZD3293 in Healthy Elderly and Alzheimer's Patients

NCT01795339 ·Status: COMPLETED ·Phase: PHASE1

Discontinuation of Cholinesterase Inhibitors for the Treatment of Severe Alzheimer's Disease

NCT02035982 ·Status: COMPLETED ·Phase: PHASE3

Study to Assess the Pharmacokinetics of CT1812 in Older Healthy Volunteers

NCT05248672 ·Status: COMPLETED ·Phase: PHASE1

Tolerability and Safety of Subcutaneous Administration of Affitope AD01 in Mild to Moderate Alzheimer's Disease

NCT00495417 ·Status: COMPLETED ·Phase: PHASE1

Multiple Ascending Dose Study of TC-5619 in Healthy Elderly Subjects and Subjects With Alzheimer's Disease

NCT01254448 ·Status: COMPLETED ·Phase: PHASE1

Open Label Extension Study Evaluating Safety and Tolerability of AAB-003 (PF-05236812) in Subject With Mild to Moderate Alzheimer's Disease

NCT01369225 ·Status: COMPLETED ·Phase: PHASE1

Multiple Dose Study Evaluating the Safety and Tolerability of NSA-789

NCT00795730 ·Status: COMPLETED ·Phase: PHASE1

Study of Uptake, Break Down and Elimination of an Investigational Drug in Healthy Volunteers

NCT00777361 ·Status: TERMINATED ·Phase: PHASE1

Study to Assess Adverse Events, Change in Disease Activity and How Oral ABBV-552 Capsules Moves Through the Body of Participants Aged 50 to 90 Years With Mild Alzheimer's Disease

NCT05771428 ·Status: COMPLETED ·Phase: PHASE2